The global anisole market size accounted for USD 99.96 million in 2024, grew to USD 105.50 million in 2025 and is projected to surpass around USD 171.39 million by 2034, representing a CAGR of 5.52% between 2024 and 2034. The North America anisole market size is evaluated at USD 29.99 million in 2024 and is expected to grow at a CAGR of 5.54% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Anisole Industry Impact
5.2. COVID-19 - Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Anisole Market Revenue and Volume, By Grade, 2024-2034
8.1.1 Above 99.5%
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Up To 99.5%
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Anisole Market Revenue and Volume, By Application, 2024-2034
9.1.1. Perfumes
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Insect Pheromones
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Pharmaceuticals
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
9.1.4. Others
9.1.4.1. Market Revenue and Volume Forecast (2021-2034)
10.1. North America
10.1.1. Market Revenue and Volume Forecast, By Grade (2021-2034)
10.1.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, By Grade (2021-2034)
10.1.3.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, By Grade (2021-2034)
10.1.4.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, By Grade (2021-2034)
10.2.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, By Grade (2021-2034)
10.2.3.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, By Grade (2021-2034)
10.2.4.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, By Grade (2021-2034)
10.2.5.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, By Grade (2021-2034)
10.2.6.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, By Grade (2021-2034)
10.3.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, By Grade (2021-2034)
10.3.3.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, By Grade (2021-2034)
10.3.4.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, By Grade (2021-2034)
10.3.5.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, By Grade (2021-2034)
10.3.6.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, By Grade (2021-2034)
10.4.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, By Grade (2021-2034)
10.4.3.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, By Grade (2021-2034)
10.4.4.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, By Grade (2021-2034)
10.4.5.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, By Grade (2021-2034)
10.4.6.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, By Grade (2021-2034)
10.5.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, By Grade (2021-2034)
10.5.3.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, By Grade (2021-2034)
10.5.4.2. Market Revenue and Volume Forecast, By Application (2021-2034)
11.1. Atul Ltd
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Benzo Chem Industries Pvt. Ltd.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Camlin Fine Sciences Ltd.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Emmennar Pharma Pvt. Ltd.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Evonik Industries AG
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Merck KGaA
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Solvay
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. SURYA LIFE SCIENCES LTD.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Thermo Fisher Scientific
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Tokyo Chemical Industry Co., Ltd.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample